World's Best Scientists 2026 revealed!
Maryalice Stetler-Stevenson

Maryalice Stetler-Stevenson

D-Index & Metrics

Medicine

D-Index
90
Citations
38289
World Ranking
12040
National Ranking
6174

Overview

Maryalice Stetler-Stevenson is affiliated with the National Institutes of Health in the United States. Their research primarily focuses on medical sciences with a significant emphasis on oncology, pathology and forensic medicine, genetics, immunology, and hematology.

Their work spans several subfields of study, including:

  • Oncology
  • Pathology and Forensic Medicine
  • Genetics
  • Immunology
  • Hematology

The scientist's main topics of research encompass:

  • CAR-T cell therapy research
  • Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Multiple Myeloma Research and Treatments
  • Protein Degradation and Inhibitors
  • Viral-associated cancers and disorders
  • Immunodeficiency and Autoimmune Disorders

Maryalice Stetler-Stevenson has contributed to numerous peer-reviewed papers. Notable recent publications include:

  • CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial, 2020, Journal of Clinical Oncology
  • Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL, 2021, Journal of Clinical Oncology
  • Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells, 2021, Blood
  • Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells, 2022, Blood Advances
  • Clinical and biological implications of target occupancy in CLL treated with the BTK inhibitor acalabrutinib, 2020, Blood

The scientist frequently collaborates with a select group of co-authors, including:

  • Constance M. Yuan
  • Hao-Wei Wang
  • Irina Marić
  • Seth M. Steinberg
  • Nirali N. Shah

Publication venues where Maryalice Stetler-Stevenson's work appears most often include:

  • Blood
  • Journal of Clinical Oncology
  • Blood Advances
  • JAMA Oncology
  • British Journal of Haematology

Best Publications

  • T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial

    Daniel W Lee;James N Kochenderfer;Maryalice Stetler-Stevenson;Yongzhi K Cui

  • Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor

    James N. Kochenderfer;Mark E. Dudley;Sadik H. Kassim;Robert P.T. Somerville

  • B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cells

    James N. Kochenderfer;Mark E. Dudley;Steven A. Feldman;Wyndham H. Wilson

  • Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19

    James N. Kochenderfer;Wyndham H. Wilson;John E. Janik;Mark E. Dudley

  • CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy.

    Terry J Fry;Nirali N Shah;Rimas J Orentas;Maryalice Stetler-Stevenson

  • ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile

    Adrian Wiestner;Andreas Rosenwald;Todd S. Barry;George Wright

  • The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia

    Yair Herishanu;Patricia Pérez-Galán;Delong Liu;Angélique Biancotto

  • Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma

    Richard L. Piekarz;Robin Frye;Maria Turner;John J. Wright

  • T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma

    Syed Abbas Ali;Victoria Shi;Irina Maric;Michael Wang

  • T Cells Genetically Modified to Express an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma

    Jennifer N. Brudno;Irina Maric;Steven D. Hartman;Jeremy J. Rose

  • Anti-CD22–chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia

    Waleed Haso;Daniel W. Lee;Nirali N. Shah;Maryalice Stetler-Stevenson

  • Efficacy of the Anti-CD22 Recombinant Immunotoxin BL22 in Chemotherapy-Resistant Hairy-Cell Leukemia

    Robert J. Kreitman;Wyndham H. Wilson;Karen Bergeron;Miranda Raggio

  • Phase I trial of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) in patients with hematologic malignancies.

    Robert J. Kreitman;Wyndham H. Wilson;Jeffrey D. White;Maryalice Stetler-Stevenson

  • IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells.

    Steven A. Rosenberg;Claude Sportès;Mojgan Ahmadzadeh;Terry J. Fry

  • Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma

    Michail S. Lionakis;Kieron Dunleavy;Mark Roschewski;Brigitte C. Widemann

  • In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1.

    Liliana Guedez;William G. Stetler-Stevenson;Linda Wolff;Jiun Wang

  • Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial.

    Mohammed Z H Farooqui;Janet Valdez;Sabrina Martyr;Georg Aue

  • High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology.

    Upendra Hegde;Armando Filie;Richard F. Little;John E. Janik

  • Growth Inhibition With Reversible Cell Cycle Arrest of Carcinoma Cells by Flavone L86-8275

    Gurmeet Kaur;Maryalice Stetler-Stevenson;Sandra Sebers;Peter Worland

  • A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease.

    M C Sneller;S E Straus;E S Jaffe;J S Jaffe

Frequent Co-Authors

Robert J. Kreitman
Robert J. Kreitman National Cancer Institute
Seth M. Steinberg
Seth M. Steinberg National Institutes of Health
Ola Landgren
Ola Landgren University of Miami
Mark Raffeld
Mark Raffeld National Institutes of Health
Wyndham H. Wilson
Wyndham H. Wilson National Institutes of Health
Ira Pastan
Ira Pastan Center for Cancer Research
Terry J. Fry
Terry J. Fry University of Colorado Denver
Gerald E. Marti
Gerald E. Marti National Institutes of Health
Elaine S. Jaffe
Elaine S. Jaffe National Institutes of Health
Diane C. Arthur
Diane C. Arthur National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Medicine but seeking alternative or complementary fields, a diverse range of online healthcare degrees can open new career doors. Many healthcare roles do not require a traditional MD, yet still offer meaningful and in-demand opportunities within the industry.

A popular choice is pursuing a master's in healthcare administration online, preparing graduates for leadership roles in hospitals, clinics, and healthcare organizations. Another advanced path is enrolling in the cheapest dnp programs online, which can lead to top clinical or academic nursing positions without attending a brick-and-mortar university.

Those interested in pharmacy can now earn a pharmacy degree online, combining flexibility with a solid foundation for pharmacy practice. Meanwhile, students with a passion for data and technology may pursue rhit programs online, paving the way for careers in health information management.

Each of these online degree pathways provides affordable, accessible options for those looking to make an impact in healthcare—either alongside or instead of medical school.

Best Scientists Citing Maryalice Stetler-Stevenson

Trending Scientists

Recently Published Articles